About this journal

*Please note that HIV Research & Clinical Practice converted to a full Open Access journal from Volume 22 (2022) and archive content will be made free to access. Please note, from 2022 the Print ISSN is not in active use as this journal is no longer published in print.

HIV Research and Clinical Practice is devoted to presenting information on the latest developments in clinical and translational research related to HIV, as well as advances in science and care that directly affect clinical practice. This journal enables readers to obtain the most up-to-date, innovative research from around the world.

In an era of increasingly well tolerated antiretroviral therapy (ART) much focus of research in the HIV field is examining the complex interplay of inflammation, ageing, and the development of chronic comorbidities in people with HIV. HIV Research and Clinical Practice aims to provide an authoritative forum for this area, with a focus on impactful clinical and translational research, as well as advances in clinical care. This international, peer-reviewed journal also intends to publish research undertaken with strong implementation science principles , whether supporting testing and treatment for HIV, best practices in prevention, or acute or chronic aspects of HIV care. The overarching principle is to improve quality of care, and quality of life, for all people with HIV, as well as those at risk of HIV acquisition also.

As access to successful HIV treatment and care improves globally, an increasing emphasis on quality of life and long-term outcomes can emerge. Aspects of holistic care based in HIV may improve, strengthen, and support healthcare systems and enable better provision of care for all. HIV has much to teach us about the contributions of a chronic pro-inflammatory infection to frailty, cancer, and renal, bone, neurocognitive, cardiovascular disease, amongst others. As biomarkers and targets for interventions are established in the context of HIV, so we hope there may be benefits for all those who age, with or without the added burden of HIV. As we understand more about healthcare systems and how heightened surveillance of people with HIV must lead to improved quality and length of life, so we hope this knowledge may also have benefits for all.

HIV Research and Clinical Practice welcomes authors and researchers to submit their work on:

• Therapeutic clinical trials, diagnostic clinical trials, or preventative clinical trials; including reports of clinical and translational research, and meta-analysis
• Observational studies relevant to HIV research and clinical practice
• Pilot studies on HIV clinical and translational research
• Studies based in implementation science methodology
• Methodological papers relating to HIV clinical care
• Translational studies describing research becoming best clinical practice
• Quality of life and pharmacoeconomic evaluations relating to HIV clinical care
• Socio-behavioural research related to improving the quality of life for people with HIV
• Expert consensus statements relevant to advances in clinical care and research

The journal adopts the UNAIDS terminology guidelines, all authors need to ensure their submission uses the preferred terminology as described in the following: https://www.unaids.org/sites/default/files/media_asset/2015_terminology_guidelines_en.pdf

HIV Research & Clinical Practice is proud to endorse the People First Charter, promoting person-first HIV & Sexual Health language. Person-first language simply puts people before their condition, recognising that people are people, and not defined by their condition. In HIV care we should avoid terms like ‘HIV-infected people’ and use ‘people with HIV’. Please consult their recommended terminology for research and publications related to HIV here when preparing your submission for the journal.

HIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data Notes, Letters to the Editor and Editorials for publication.

Author Benefits

The prestigious and experienced members of our international Editorial Board will guide you from submission to publication.

Our Author Services page provides you with tips and tricks to promote your research on social media and through your network. This includes 50 free e-prints to share with whomever you choose.

We have enabled easy tracking to measure the impact your paper makes with the help of My Authored Works.

Editor in Chief

Tristan Barber, (Royal Free Hospital, London, UK)


Editorial Board

Judith A. Aberg, (Icahn School of Medicine at Mount Sinai, NY, USA)

Joseph Cherabie, (Division of Infectious Diseases, Washington University St. Louis; CDC Midwest 2B Capacity Building Assistance Program; St. Louis STI/ HIV Prevention Training Center, St Louis, MO, USA)

Karine Dubé, (Division of Infectious Diseases and Global Public Health, University of California San Diego (UCSD) School of Medicine, CA, USA)

Sidd Kogilwaimath, (Division of Infectious Diseases and Geographic Medicine, UT Southwestern Medical Center, Dallas, TX, USA)

Carlee Moser, (Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, MA, USA)

Takashi Muramatsu, (Department of Laboratory Medicine, Tokyo Medical University Hospital, Tokyo, Japan)

Hideta Nakamura, (Division of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus Graduate School of Medicine, Okinawa, Japan)

Silvia Nozza, (Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy)

Oana Sandulescu, (Carol Davila University of Medicine and Pharmacy and National Institute for Infectious Diseases "Prof.Dr. Matei Bals", Bucharest, Romania)

Jochen Schneider, (Technical University of Munich, Munich, Germany) 

Agata Skrzat-Klapaczyńska, (Department of Infectious Diseases for Adults, Medical University of Warsaw and Hospital for Infectious Diseases, Warsaw, Poland)

Colette Smith, (Institute of Global Health, University College London, London, UK)

Ricardo Roberto de Souza Fonseca, (Federal University of Pará, Belém, Brazil)

Nnakelu Eriobu, (Institute of Human Virology Nigeria, Abuja, Nigeria)

Onu Adamu (Garki Hospital, Abuja, Nigeria)


Founding Editor-in-Chief: HIV Clinical Trials

Maurice J Staquet

Emeritus Editors

Caroline A. Sabin, (Institute for Global Health, University College London, London, UK)

Alain Lafeuillade, (Institute of Human Virology, University of Maryland School of Medicine, MD, USA)

Jordan E. Lake, (McGovern Medical School, University of Texas, TX, USA)

David Hardy, (Division of Infectious Diseases, Johns Hopkins University School of Medicine, MD, USA) 

News, offers and calls for papers